However, the apparent dual role of PAX5 in breast cancer, as both a tumor suppressor and a potential promoter of aggressive phenotypes, may be attributed to the heterogeneity of breast cancer subtypes and the context-dependent nature of transcriptional regulation. The gene discussed is PAX5; the disease is breast carcinoma.